FDA Approves Firdapse® (amifampridine) for the Treatment of Lambert-Eaton Myasthenic Syndrome (LEMS) – First evidenced-based medicine approved to treat LEMS – Catalyst Pathways™ designed to facilitate access to Firdapse® and provide dedicated patient...